Israel - hebraisk - Ministry of Health

abbvie biopharmaceuticals ltd, israel - brimonidine tartrate; timolol as maleate - תמיסה לעין - timolol as maleate 0.5 %w/v; brimonidine tartrate 0.2 %w/v - brimonidine - brimonidine - combigan is indicated for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Israel - hebraisk - Ministry of Health

teva pharmaceutical industries ltd, israel - brimonidine tartrate - תמיסה לעין - brimonidine tartrate 0.15 %w/v - brimonidine - brimonidine - for the lowering of intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Israel - hebraisk - Ministry of Health

rafa laboratories ltd - dorzolamide as hydrochloride - תמיסה לעין - dorzolamide as hydrochloride 20 mg/ml - dorzolamide - dorzolamide - for the treatment of eleveated intraocular pressure in patients with ocular hypertension, open-angle glaucoma and in some patients secondary glaucoma.

Israel - hebraisk - Ministry of Health

novartis israel ltd - brinzolamide - תרחיף לעין - brinzolamide 1 % - brinzolamide - brinzolamide - alcon azopt is indicated to decrease elevated intraocular pressure in: ocular hypertension open-angle glaucoma as monotherapy in patients unresponsive to beta-blockers or in patients in whom beta-blockers are contra-indicated or as adjunctive therapy to beta-blockers.

Israel - hebraisk - Ministry of Health

novartis israel ltd - timolol as maleate; travoprost - תמיסה לעין - travoprost 40 mcg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intraocular pressure (iop) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Israel - hebraisk - Ministry of Health

novartis israel ltd - brinzolamide; timolol as maleate - תרחיף לעין - brinzolamide 10 mg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intra-ocular pressure (iop) in adult patients with open-angle glaucoma or ocular hypertension for whom monotherapy provides insufficient iop reduction.

Israel - hebraisk - Ministry of Health

allergan israel ltd - bimatoprost - תמיסה לעין - bimatoprost 0.3 mg/ml - bimatoprost - bimatoprost - reduction of elevated intraocular pressure in chronic open angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).

Israel - hebraisk - Ministry of Health

novartis israel ltd - travoprost - תמיסה לעין - travoprost 0.004 %w/v - travoprost - travoprost - for the reduction of elevated intra ocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other iop lowering medications or insufficiently responsive to another iop lowering medication.

Israel - hebraisk - Ministry of Health

rafa laboratories ltd - tafluprost - תמיסה לעין - tafluprost 15 mcg/ml - tafluprost - tafluprost - reduction of elevated intraocular pressure in open angle glaucoma and ocular hypertension.as monotherapy in patients • who would benefit from preservative free eye drops • insufficiently responsive to first line therapy • intolerant or contra-indicated to first line therapyas adjunctive therapy to beta-blockers.

Israel - hebraisk - Ministry of Health

abbvie biopharmaceuticals ltd, israel - epinastine hydrochloride - תמיסה לעין - epinastine hydrochloride 0.05 %w/v - epinastine - epinastine - treatment of the symptoms of seasonal allergic conjunctivitis.